Dr Andrew Pattison is a Research Fellow in the Abud and Lyras laboratories at the Monash Biomedicine Discovery Institute, Monash University (2023–present). HIs research focuses on the analysis of large colorectal cancer spatial transcriptomics datasets, alongside providing bioinformatics expertise across transcriptomic, metabolomic and genomic projects. His expertise encompasses computational biology, with particular strength in single-cell, spatial, and multi-omics approaches applied to cancer biology and immunology.

Dr Pattison trained in both wet-lab and computational biology during his PhD in Biochemistry and Computational Biology at Monash University (2014–2018), where he investigated alternative mRNA polyadenylation in breast cancer. He subsequently joined the University of Melbourne Centre for Cancer Research as a Cancer Genome Analyst (2018–2021), contributing to a large multi-omics study of pheochromocytomas and paragangliomas, integrating bulk RNA-seq, single-cell RNA-seq, and whole genome sequencing. From 2021 to 2023, Dr Pattison worked in industry as a Senior Scientist in Computational Biology at oNKo-Innate, where he analysed proprietary datasets, reanalysed public scRNA-seq data, and developed bioinformatics tools to identify novel drug targets in immuno-oncology.

Dr Pattison actively collaborates with experimental biologists and clinicians, contributing to multidisciplinary projects that combine cutting-edge bioinformatics with translational research. His work supports the discovery of novel mechanisms in cancer biology and informs the development of precision medicine strategies.